Cargando…

Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al

Detalles Bibliográficos
Autores principales: Brunner, Hermine, Graham Lomax, Kathleen, Levy, Stephane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437052/
https://www.ncbi.nlm.nih.gov/pubmed/25512026
http://dx.doi.org/10.1002/art.38992
_version_ 1782372170803970048
author Brunner, Hermine
Graham Lomax, Kathleen
Levy, Stephane
author_facet Brunner, Hermine
Graham Lomax, Kathleen
Levy, Stephane
author_sort Brunner, Hermine
collection PubMed
description
format Online
Article
Text
id pubmed-4437052
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-44370522015-05-28 Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al Brunner, Hermine Graham Lomax, Kathleen Levy, Stephane Arthritis Rheumatol Letters BlackWell Publishing Ltd 2015-03 2015-02-25 /pmc/articles/PMC4437052/ /pubmed/25512026 http://dx.doi.org/10.1002/art.38992 Text en Copyright © 2015 by the American College of Rheumatology
spellingShingle Letters
Brunner, Hermine
Graham Lomax, Kathleen
Levy, Stephane
Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al
title Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al
title_full Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al
title_fullStr Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al
title_full_unstemmed Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al
title_short Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al
title_sort half-life and safety of canakinumab in pediatric patients: comment on the article by ilowite et al
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437052/
https://www.ncbi.nlm.nih.gov/pubmed/25512026
http://dx.doi.org/10.1002/art.38992
work_keys_str_mv AT brunnerhermine halflifeandsafetyofcanakinumabinpediatricpatientscommentonthearticlebyilowiteetal
AT grahamlomaxkathleen halflifeandsafetyofcanakinumabinpediatricpatientscommentonthearticlebyilowiteetal
AT levystephane halflifeandsafetyofcanakinumabinpediatricpatientscommentonthearticlebyilowiteetal